Catharine I. Paules, MD; Robert W. Eisinger, PhD; Hilary D. Marston, MD, MPH; Anthony S. Fauci, MD
Note: This article is based on a lecture given by Anthony S. Fauci, MD, on 30 March 2017 in San Diego, California, at the Internal Medicine Meeting 2017 of the American College of Physicians.
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-2496.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer and Johnson & Johnson.
Requests for Single Reprints: Catharine I. Paules, MD, Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Building 31, Suite 7A03, Bethesda, MD 20892; e-mail, catharine.paules@nih.gov.
Current Author Addresses: Drs. Paules, Eisinger, Marston, and Fauci: Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Building 31, Suite 7A03, Bethesda, MD 20892.
Author Contributions: Conception and design: C.I. Paules, R.W. Eisinger, A.S. Fauci.
Analysis and interpretation of the data: R.W. Eisinger.
Drafting of the article: C.I. Paules, R.W. Eisinger, H.D. Marston, A.S. Fauci.
Critical revision of the article for important intellectual content: R.W. Eisinger.
Final approval of the article: C.I. Paules, R.W. Eisinger, H.D. Marston, A.S. Fauci.
Administrative, technical, or logistic support: A.S. Fauci.
Collection and assembly of data: R.W. Eisinger.
Presidential administrations face any number of unexpected crises during their tenure, and global pandemics are among the most challenging. As of January 2017, one of the authors had served under 5 presidents as the director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. During each administration, the government faced unexpected pandemics, ranging from the HIV/AIDS pandemic, which began during the Reagan administration, to the recent Zika outbreak in the Americas, which started during the Obama administration. These experiences underscored the need to optimize preparation for and response to these threats whenever and wherever they emerge. This article recounts selected outbreaks occurring during this period and highlights lessons that were learned that can be applied to the infectious disease threats that will inevitably be faced in the current presidential administration and beyond.
Paules CI, Eisinger RW, Marston HD, Fauci AS. What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats. Ann Intern Med. 2017;167:805–811. doi: 10.7326/M17-2496
Download citation file:
© 2019
Published: Ann Intern Med. 2017;167(11):805-811.
DOI: 10.7326/M17-2496
Published at www.annals.org on 14 November 2017
HIV, Infectious Disease, Prevention/Screening.
Results provided by: